Anti Venom Market
According to Intent Market Research, the Anti-Venom Market is expected to grow from USD 1.7 Billion in 2024-e at a CAGR of 11.5% to touch USD 3.2 Billion by 2030. The Anti-Venom Market is dominated by key players such as Baxter International Inc., Merck & Co., Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., VINS Bioproducts Ltd., and Haffkine Bio-Pharmaceutical Corporation Ltd.